Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivier Muis-Pistor

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Joint Bone Spine|October 17, 2015
Antisynthetase syndrome treated with tocilizumabAmandine Beaumel, Olivier Muis-Pistor, Jacques-Guy Tebib, et al.
Joint Bone Spine|June 9, 2016
Early treatment of reactive arthritis with etanercept and 2 years follow-upAudrey Courcoul, Olivier Muis Pistor, Jacques G Tebib, et al.
Joint Bone Spine|October 1, 2013
Spinal cord compression revealing a lambda light chain multiple myelomaCécile-Audrey Durel, Camille Vigne, Olivier Muis-Pistor, et al.
Plos One|February 16, 2017
Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective studyNathalie Balandraud, Gaetan Texier, Emmanuel Massy, et al.
The Lancet. Rheumatology|February 1, 2021
First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infectionLea Perrot, Marie Hemon, Jean-Marc Busnel, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Joint Bone Spine|October 17, 2015
Antisynthetase syndrome treated with tocilizumabAmandine Beaumel, Olivier Muis-Pistor, Jacques-Guy Tebib, et al.
Joint Bone Spine|June 9, 2016
Early treatment of reactive arthritis with etanercept and 2 years follow-upAudrey Courcoul, Olivier Muis Pistor, Jacques G Tebib, et al.
Joint Bone Spine|October 1, 2013
Spinal cord compression revealing a lambda light chain multiple myelomaCécile-Audrey Durel, Camille Vigne, Olivier Muis-Pistor, et al.
Plos One|February 16, 2017
Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective studyNathalie Balandraud, Gaetan Texier, Emmanuel Massy, et al.
The Lancet. Rheumatology|February 1, 2021
First flare of ACPA-positive rheumatoid arthritis after SARS-CoV-2 infectionLea Perrot, Marie Hemon, Jean-Marc Busnel, et al.
Pageof 1